The industry's challenge is to develop and proactively propose forward-looking credible alternatives that address the tensions within the Government, benefit the system, and progress its long-term objectives. These alternatives can delay and potentially prevent the more undesirable options.
Developing and proactively proposing credible alternatives will delay or prevent worst outcomes
March 20, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Reform was justified because a committee prioritising clinical considerations was 'culturally' problematic
January 4, 2026 - - Latest News -
AdAlta and SHcell launch cancer collaboration to progress breakthrough CAR-T therapy
January 2, 2026 - - Australian Biotech -
Cabinet documents from the year that led to transformational changes
January 1, 2026 - - Latest News -
US pricing push gets real with Australia included in comparison list
December 22, 2025 - - Latest News -
Parsimony has unfortunately become an enduring test of the institution's legitimacy
December 20, 2025 - - Latest News -
PBAC delivers a broad range of outcomes in November, including for obesity
December 20, 2025 - - Latest News -
Takeda’s next-generation psoriasis therapy delivers landmark Phase 3 results
December 19, 2025 - - Latest News

